Team Building the viral
platform of the future.

The Codagenix team and its founders pioneered the use of codon deoptimization to construct groundbreaking vaccines and virotheraputics. We are now pushing this proven method into the clinic and beyond.

Leadership team

Paul Grint, MD

Executive Chairman & Interim CEO

Steffen Mueller, PhD

Co-Founder, President & Chief Scientific Officer

Kimber Poffenberger, PhD

Chief Strategy Officer

Jeffrey Fu, PhD

Chief Business Officer

Tyler Cook

Chief Financial Officer

Test tubes with abstract representation of DNA double helix and sequencing within.

We bring a wealth of experience in virology, computational science and patient care to developing a platform of viral therapeutics and vaccines capable of overcoming our biggest obstacles to global health.